Abstract
The prognosis of cancer depends on both tumor and patient biological characteristics. Within host biological variables, lymphocytopenia is associated with a poor prognosis in advanced cancer patients. Moreover, lymphocyte number has been proven to be influenced by both tumor growth and antitumor therapies, among them radiotherapy (RT) would represent the most lymphocytopenic treatment, particularly the pelvic irradiation. The present investigation was performed to evaluate the effects of brain irradiation on lymphocyte count in relation to the efficacy of treatment, and those induced by the pineal hormone melatonin (MLT) on the radiosensitivity of brain metastases due to radioresistant neoplasms. In a first study, we evaluated 70 solid tumor patients with brain metastases, who were treated by brain RT. In a second study, we evaluated the influence of a concomitant MLT administration (20 mg/day orally in the evening) in 14 patients treated by RT for brain metastases due to lung adenocarcinoma or large cell carcinoma, by comparing the results to those obtained in a control-group of 28 comparable patients treated by RT alone. In both studies, the dose of brain RT was 30 Gy. Patients who achieved an objective regression of brain metastases showed a statistically significant increase in lymphocyte mean number with respect to those found in patients who had no benefit. On the same way, the concomitant administration of MLT significantly increased the percent of partial or complete brain metastasis regression with respect to the results observed in patients treated by the only RT. The results of this preliminary study seem to suggest that brain irradiation-induced increase in lymphocyte amount may predict the efficacy of the treatment in patients with brain metastases due to solid neoplasms, and that the concomitant administration of neuroactive substances capable of modulating immune system and tissue radiosensitivity, such as the pineal indole MLT, may modulate the biological effects and the efficacy of brain irradiation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Atzpodien J, Kirchner H (1990) Cancer, cytokines and cytotoxic cells. Interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 8:1–11
Ehrke MJ, Mihilich E, Berd D, Mastrangelo MJ (1989) Effects of anticancer drugs on the immune system. Semin Oncol 16:230–239
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. J Exp Med 155:1823–1841
Lissoni P, Fumagalli L, Paolorossi F, Mandalà M (1999) Changes in lymphocyte number during cancer chemiotherapy and their relation to clinical response. Int J Biol Markers 14:115–117
Lissoni P, Meregalli S, Bonetto E, Mancuso M, Brivio F, Colciago M, Gardani G (2005) Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynaecologic neoplasms. J Biol Homeost Agents 19:153–157
Lissoni P, Rovelli F, Brivio F, Fumagalli L, Brera G (2008) A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients. In Vivo 22:397–400
Lissoni P, Brivio F, Fumagalli L, Messina G, Meregalli S, Porro G, Rovelli F, Vigorè L, Tisi E, D’Amico G (2009) Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients. Anticancer Res 2900 May; 29(5):1847–1852
Louagie H, van Eijkeren M, Philippe J, Thierens H, de Ridder L (1999) Changes in peripheral blood lymÂphocyte subsets in patients undergoing radiotherapy. Int J Radiat Biol 75:767–771
Maestroni GJM (1993) The immunoneuroendocrine role of melatonin. J Pineal Res 14:1–10
Reiter RJ, Tan D, Sainz RM, Mayo JC, Lopez-Burillo S (2002) Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002 Oct; 54(10):1299–1321
Riesco A (1970) Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 25:135–140
Rubinow DR (1990) Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10:79–82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lissoni, P. (2012). Metastatic Brain Irradiation-Induced Lymphocytosis Predicts Efficacy of Radiotherapy. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 9. Tumors of the Central Nervous System, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5488-1_7
Download citation
DOI: https://doi.org/10.1007/978-94-007-5488-1_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5487-4
Online ISBN: 978-94-007-5488-1
eBook Packages: MedicineMedicine (R0)